Acquired by Illumina
Industries Developer PlatformHealth CareInformation TechnologyDiversity Spotlight (US Headquarters Only) Women LedHeadquarters Regions San Francisco Bay Area, Silicon Valley, West Coast Closed Date Jan 7, 2013 Founded Date 2002 Founders Richard Rava Operating Status Closed Last Funding Type Series C Also Known As ARTEMIS HEALTH INC Legal Name Verinata Health, Inc
Company Type For Profit
Contact Email info@verinata.com Phone Number (650)632-1680
Verinata is driven by a sole, extraordinary purpose – maternal and fetal health. Our initial focus is to develop and offer non-invasive tests for early identification of fetal chromosomal abnormalities using our proprietary technologies. We aim to reduce the anxiety associated with today's multi-step process, the unacceptable false-positive
rates, the non-specific and sometimes confusing results of current prenatal screening methods, as well as the risk of current invasive procedures. In support of national guidelines recommending first trimester aneuploidy risk assessment, we believe women who desire such an assessment should be offered a single blood draw test with a definitive result. Verinata is conducting a prospective, blinded pivotal study to clinically validate the sensitivity and specificity of its first prenatal test on a large scale with results of the study expected in 2011.
Transaction Name Verinata Health acquired by IlluminaAcquired by IlluminaAnnounced Date Jan 7, 2013 Price $350M